Human risk assessment of di-isobutyl phthalate through the application of a developed physiologically based pharmacokinetic model of di-isobutyl phthalate and its major metabolite mono-isobutyl phthalate
2020 ◽
Vol 94
(7)
◽
pp. 2377-2400
◽
2015 ◽
Vol 73
(2)
◽
pp. 530-543
◽
2017 ◽
Vol 92
(3)
◽
pp. 1113-1131
◽
1995 ◽
Vol 46
(2)
◽
pp. 155-163
◽